DNE Group: The time is now for life sciences

China’s life sciences market is generating significant investor interest; investors seeking exposure to the segment need a trusted working partner with a proven track record, says DNE Group founder and CEO Sun Dongping

By

PERE Staff

1 May 2022•7 mins read

Sponsored Sponsored

Related articles

alt

Redevco on scaling performance through active asset management

1 July 2026 · 6 mins read

alt

Newport Capital Partners on the resurgence of everyday essential retail

1 July 2026 · 7 mins read

alt

Northwood Investors on open-air retail gaining momentum

1 July 2026 · 8 mins read

alt

Schroders Capital on why recapitalization is more than just a liquidity tool

1 July 2026 · 7 mins read

alt

Partners Group on navigating the ‘complex middle’ of bespoke mid-market secondaries

1 July 2026 · 8 mins read

alt

StepStone Group: Another record year for secondaries

1 July 2026 · 6 mins read

alt

Evercore: The natural emergence of continuation vehicles

1 July 2026 · 6 mins read

motif